| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 7, Issue 8 1013-1021, Copyright © 1996 by American Association of Cancer Research
ARTICLES |
PH Brown, SH Kim, SC Wise, AL Sabichi and MJ Birrer
Biomarkers and Prevention Research Branch, Division of Clinical Sciences, National Cancer Institute, Rockville, Maryland 20850, USA.
We have previously described a dominant-negative mutant of cJun that lacks the transactivation domain (TAD) of cJun and prevents AP-1-mediated transcriptional activation by quenching endogenous Jun or Fos proteins. We now report the development of a panel of cJun mutants that have inactivating mutations in the TAD, DNA-binding domain (DBD), or leucine zipper domain. These mutants are all unable to activate transcription, but only TAD and DBD mutants function in a dominant-negative fashion by inhibiting both cJun-induced transcriptional activation and transformation induced by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate in ras-transfected rat embryo cells. Although the TAD and DBD mutants both function as transdominant inhibitors, they work through different mechanisms and with different inhibitory potencies. The DBD mutants, which function by inhibiting DNA binding, are relatively weak inhibitors, whereas the TAD mutants inhibit by quenching and are much more potent. Dimerization assays demonstrate that mutations in the DBD decrease the dimerization affinity of these mutants with cJun. These results demonstrate that the most potent dominant-negative mutants of cJun are proteins that have intact DBDs and quench the activity of the endogenous transcription factors.
This article has been cited by other articles:
![]() |
N. Smadja-Lamere, M.-C. Boulanger, C. Champagne, P. E. Branton, and J. N. Lavoie JNK-mediated Phosphorylation of Paxillin in Adhesion Assembly and Tension-induced Cell Death by the Adenovirus Death Factor E4orf4 J. Biol. Chem., December 5, 2008; 283(49): 34352 - 34364. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. DeNardo, H.-T. Kim, S. Hilsenbeck, V. Cuba, A. Tsimelzon, and P. H. Brown Global Gene Expression Analysis of Estrogen Receptor Transcription Factor Cross Talk in Breast Cancer: Identification of Estrogen-Induced/Activator Protein-1-Dependent Genes Mol. Endocrinol., February 1, 2005; 19(2): 362 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Wang, F. Y. Wu, H. Chen, M. Shamay, Q. Zheng, and G. S. Hayward Early Activation of the Kaposi's Sarcoma-Associated Herpesvirus RTA, RAP, and MTA Promoters by the Tetradecanoyl Phorbol Acetate-Induced AP1 Pathway J. Virol., April 15, 2004; 78(8): 4248 - 4267. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Adiseshaiah, S. R. Papaiahgari, H. Vuong, D. V. Kalvakolanu, and S. P. Reddy Multiple cis-Elements Mediate the Transcriptional Activation of Human fra-1 by 12-O-Tetradecanoylphorbol-13-acetate in Bronchial Epithelial Cells J. Biol. Chem., November 28, 2003; 278(48): 47423 - 47433. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. H. Shen, J. Godlewski, J. Zhu, P. Sathyanarayana, V. Leaner, M. J. Birrer, A. Rana, and G. Tzivion Cross-talk between JNK/SAPK and ERK/MAPK Pathways: SUSTAINED ACTIVATION OF JNK BLOCKS ERK ACTIVATION BY MITOGENIC FACTORS J. Biol. Chem., July 11, 2003; 278(29): 26715 - 26721. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bowen, M. Birrer, and E. P. Gelmann Retinoblastoma Protein-mediated Apoptosis After gamma -Irradiation J. Biol. Chem., November 15, 2002; 277(47): 44969 - 44979. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lu, F. Zhang, A. Gupta, and J. Liu Blockade of AP1 Transactivation Abrogates the Abnormal Expression of Breast Cancer-specific Gene 1 in Breast Cancer Cells J. Biol. Chem., August 23, 2002; 277(35): 31364 - 31372. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shah, M. J. Pishvaian, V. Easwaran, P. H. Brown, and S. W. Byers The Role of Cadherin, beta -Catenin, and AP-1 in Retinoid-regulated Carcinoma Cell Differentiation and Proliferation J. Biol. Chem., July 5, 2002; 277(28): 25313 - 25322. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Chen, L. Ma, N. Al-Ansari, and B. Shneider The Role of AP-1 in the Transcriptional Regulation of the Rat Apical Sodium-dependent Bile Acid Transporter J. Biol. Chem., October 12, 2001; 276(42): 38703 - 38714. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P.-c. Hu, B. L. Harvat, S. S. Hook, X. Shen, X.-F. Wang, and A. R. Means c-Jun Enhancement of Cyclic Adenosine 3',5'-Monophosphate Response Element-Dependent Transcription Induced by Transforming Growth Factor-{beta} Is Independent of c-Jun Binding to DNA Mol. Endocrinol., December 1, 1999; 13(12): 2039 - 2048. [Abstract] [Full Text] |
||||
![]() |
D. Kardassis, P. Papakosta, K. Pardali, and A. Moustakas c-Jun Transactivates the Promoter of the Human p21WAF1/Cip1 Gene by Acting as a Superactivator of the Ubiquitous Transcription Factor Sp1 J. Biol. Chem., October 8, 1999; 274(41): 29572 - 29581. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Si, Q. Wang, and L. Mei Essential Roles of c-JUN and c-JUN N-Terminal Kinase (JNK) in Neuregulin-Increased Expression of the Acetylcholine Receptor epsilon -Subunit J. Neurosci., October 1, 1999; 19(19): 8498 - 8508. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sabbah, D. Courilleau, J. Mester, and G. Redeuilh Estrogen induction of the cyclin D1 promoter: Involvement of a cAMP response-like element PNAS, September 28, 1999; 96(20): 11217 - 11222. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Lee, C. Albanese, R. J. Stenger, G. Watanabe, G. Inghirami, G. K. Haines III, M. Webster, W. J. Muller, J. S. Brugge, R. J. Davis, et al. pp60v-src Induction of Cyclin D1 Requires Collaborative Interactions between the Extracellular Signal-regulated Kinase, p38, and Jun Kinase Pathways. A ROLE FOR cAMP RESPONSE ELEMENT-BINDING PROTEIN AND ACTIVATING TRANSCRIPTION FACTOR-2 IN pp60v-src SIGNALING IN BREAST CANCER CELLS J. Biol. Chem., March 12, 1999; 274(11): 7341 - 7350. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-W. Chow, M. Rincon, and R. J. Davis Requirement for Transcription Factor NFAT in Interleukin-2 Expression Mol. Cell. Biol., March 1, 1999; 19(3): 2300 - 2307. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Dorman and S. E. Johnson Activated Raf Inhibits Myogenesis through a Mechanism Independent of Activator Protein 1-mediated Myoblast Transformation J. Biol. Chem., August 25, 2000; 275(35): 27481 - 27487. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Vuong, T. Patterson, P. Shapiro, D. V. Kalvakolanu, R. Wu, W.-Y. Ma, Z. Dong, S. R. Kleeberger, and S. P. M. Reddy Phorbol Ester-induced Expression of Airway Squamous Cell Differentiation Marker, SPRR1B, Is Regulated by Protein Kinase Cdelta /Ras/MEKK1/MKK1-dependent/AP-1 Signal Transduction Pathway J. Biol. Chem., October 6, 2000; 275(41): 32250 - 32259. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zhu, K. Gagnidze, J. H. M. Gemberling, and S. E. Plevy Characterization of an Activation Protein-1-binding Site in the Murine Interleukin-12 p40 Promoter. DEMONSTRATION OF NOVEL FUNCTIONAL ELEMENTS BY A REDUCTIONIST APPROACH J. Biol. Chem., May 18, 2001; 276(21): 18519 - 18528. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Potapova, S. Basu, D. Mercola, and N. J. Holbrook Protective Role for c-Jun in the Cellular Response to DNA Damage J. Biol. Chem., July 20, 2001; 276(30): 28546 - 28553. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |